Twist Bioscience's 15min chart sees Bollinger Bands expand upward, KDJ Golden Cross.

Twist Bioscience's 15-minute chart exhibits an upward trend, as evidenced by the expanding Bollinger Bands and the Golden Cross of the KDJ indicator at 07/09/2025 15:30. This suggests that the market is being driven by strong buying interest, and the momentum of the stock price is shifting towards the upside, with potential for further increase.

Twist Bioscience Corporation (TWST) has seen a notable upward trend in its stock price, as indicated by the expanding Bollinger Bands and the Golden Cross of the KDJ indicator at 07/09/2025 15:30. This suggests a strong buying interest and a potential for further price increases.

The company's recent operational enhancements have played a significant role in this upward trajectory. Twist Bioscience has accelerated the turnaround time for its gene fragments to just two business days, regardless of the gene fragments' length, volume, configuration, or delivery format [1]. This enhanced service is accompanied by competitive pricing at seven cents per base pair, ensuring no hidden fees and providing flexibility and transparency to researchers across various fields including protein engineering, antibody discovery, and diagnostic assays.

Additionally, Twist Bioscience's CEO, Emily M. Leproust, sold 476 shares of Common Stock on July 2, 2025, at a price of $36.193 per share, totaling $17,227, to cover tax withholding obligations related to the vesting of Restricted Stock Units. This transaction does not appear to have a significant impact on the company's overall financial health, as Leproust still directly owns 645,306 shares of Twist Bioscience Corp. [2].

The company's market capitalization stands at $2.21 billion, reflecting its pivotal position in the life sciences segment. Twist Bioscience's automated workflow and scalable infrastructure enable the rapid synthesis and delivery of synthetic DNA globally, positioning it as a key partner for researchers aiming for precision and efficiency in their scientific endeavors.

With a strong operational foundation and positive market indicators, Twist Bioscience continues to innovate and expand its partnerships, such as the recent collaboration with Element Biosciences, Inc., to transform next-generation sequencing workflows with co-developed end-to-end solutions [3].

References:
[1] https://www.gurufocus.com/news/2961054/twist-bioscience-expands-express-delivery-turnaround-time-to-all-gene-fragments-regardless-of-format-twst-stock-news
[2] https://www.tradingview.com/news/tradingview:d58381a4d1bdb:0-twist-bioscience-ceo-sells-shares-to-cover-tax-obligations/
[3] https://www.marketscreener.com/quote/stock/TWIST-BIOSCIENCE-CORPORAT-46874562/